|
81
|
306
|
9bseA |
Structure of the sars-cov-2 main protease in complex with inhibitor yr-b-165 |
|
79
|
306
|
9bqzA |
Structure of the sars-cov-2 main protease in complex with inhibitor x11 |
|
78
|
306
|
9bqyA |
Structure of the sars-cov-2 main protease in complex with inhibitor r70 |
|
82
|
306
|
9bqtA |
Structure of the sars-cov-2 main protease in complex with inhibitor r80 |
|
87
|
306
|
9bqqA |
Structure of the sars-cov-2 main protease in complex with inhibitor r81 |
|
85
|
306
|
9bsfA |
Structure of the sars-cov-2 main protease in complex with inhibitor sr-a-171 |
|
84
|
305
|
9bbsA |
Sars-cov-2 mpro in complex with compound 6d inhibitor |
|
80
|
304
|
9bbwA |
Sars-cov-2 mpro in complex with compound 6k inhibitor |
|
87
|
306
|
9bqpA |
Structure of the sars-cov-2 main protease in complex with inhibitor r79 |
|
82
|
306
|
9bsiA |
Structure of the sars-cov-2 main protease in complex with inhibitor sr-b-7 |
|
83
|
306
|
9bs8A |
Structure of the sars-cov-2 main protease in complex with inhibitor yr-b-107 |
|
83
|
306
|
9bqmA |
Structure of the sars-cov-2 main protease in complex with inhibitor vb-a-26 |
|
88
|
306
|
9br1A |
Structure of the sars-cov-2 main protease in complex with inhibitor vb-a-70 |
|
87
|
305
|
9bbxA |
Sars-cov-2 mpro in complex with compound 6l inhibitor |
|
87
|
305
|
9bbqA |
Sars-cov-2 mpro in complex with compound 6c inhibitor |
|
85
|
300
|
9bbyA |
Sars-cov-2 mpro in complex with compound 18b inhibitor |
|
87
|
303
|
9bbuA |
Sars-cov-2 mpro in complex with compound 6h inhibitor |
|
77
|
304
|
9bbtA |
Sars-cov-2 mpro in complex with compound 6f inhibitor |
|
83
|
304
|
9bbvA |
Sars-cov-2 mpro in complex with compound 6j inhibitor |
|
89
|
302
|
9bbzA |
Sars-cov-2 mpro in complex with compound 18d inhibitor |
|
85
|
305
|
9bbrA |
Sars-cov-2 mpro in complex with compound 6b inhibitor |
|
77
|
305
|
9bc0A |
Sars-cov-2 mpro in complex with compound 18r inhibitor |
|
85
|
301
|
9bbpA |
Sars-cov-2 mpro in complex with compound 12d inhibitor |
|
86
|
302
|
9bc1A |
Sars-cov-2 mpro in complex with peptide mimetic inhibitor |
|
90
|
305
|
8zq8A |
Sars-cov-2 3cl protease in complex with macrocyclic inhibitor cg-1039 |
|
85
|
302
|
8ywyA |
Crystal structure of sars-cov-2 main protease e166n mutant in complex with bofutrelvir |
|
83
|
305
|
8wz0A |
Sars-cov-2 3clpro bound to covalent inhibitor |
|
83
|
296
|
8ywzA |
Crystal structure of sars-cov-2 main protease h163a mutant in complex with bofutrelvir |
|
83
|
301
|
7i18A |
Pandda analysis group deposition -- main protease (sars-cov-2) in complex with fragment d04 from the f2x-entry screen in orthorhombic space group |
|
85
|
300
|
7i1dA |
Pandda analysis group deposition -- main protease (sars-cov-2) in complex with fragment f04 from the f2x-entry screen in orthorhombic space group |
|
84
|
306
|
7i16A |
Pandda analysis group deposition -- main protease (sars-cov-2) in complex with fragment c07 from the f2x-entry screen in orthorhombic space group |
|
81
|
300
|
7i1gA |
Pandda analysis group deposition -- main protease (sars-cov-2) in complex with fragment g09 from the f2x-entry screen in orthorhombic space group |
|
79
|
301
|
7i1iA |
Pandda analysis group deposition -- main protease (sars-cov-2) in complex with fragment h03 from the f2x-entry screen in orthorhombic space group |
|
84
|
301
|
7i19A |
Pandda analysis group deposition -- main protease (sars-cov-2) in complex with fragment d08 from the f2x-entry screen in orthorhombic space group |
|
86
|
301
|
7i1cA |
Pandda analysis group deposition -- main protease (sars-cov-2) in complex with fragment e11 from the f2x-entry screen in orthorhombic space group |
|
82
|
301
|
7i15A |
Pandda analysis group deposition -- main protease (sars-cov-2) in complex with fragment c02 from the f2x-entry screen in orthorhombic space group |
|
81
|
306
|
7i1jA |
Pandda analysis group deposition -- main protease (sars-cov-2) in complex with fragment h11 from the f2x-entry screen in orthorhombic space group |
|
81
|
300
|
7i14A |
Pandda analysis group deposition -- main protease (sars-cov-2) in complex with fragment b08 from the f2x-entry screen in orthorhombic space group |
|
82
|
301
|
7i13A |
Pandda analysis group deposition -- main protease (sars-cov-2) in complex with fragment b05 from the f2x-entry screen in orthorhombic space group |
|
84
|
300
|
7i1eA |
Pandda analysis group deposition -- main protease (sars-cov-2) in complex with fragment g03 from the f2x-entry screen in orthorhombic space group |
|
81
|
301
|
7i1hA |
Pandda analysis group deposition -- main protease (sars-cov-2) in complex with fragment g10 from the f2x-entry screen in orthorhombic space group |
|
84
|
301
|
7i1fA |
Pandda analysis group deposition -- main protease (sars-cov-2) in complex with fragment g04 from the f2x-entry screen in orthorhombic space group |
|
85
|
306
|
7i1aA |
Pandda analysis group deposition -- main protease (sars-cov-2) in complex with fragment d11 from the f2x-entry screen in orthorhombic space group |
|
83
|
300
|
7i17A |
Pandda analysis group deposition -- main protease (sars-cov-2) in complex with fragment c10 from the f2x-entry screen in orthorhombic space group |
|
79
|
301
|
9rhtA |
Structure of 3cl protease with a bound inhibitor |
|
78
|
301
|
9rhxA |
Sars-cov-2 main protease with a bound inhibitor |
|
77
|
306
|
9ri8A |
Sars-cov-2 with a bound inhibitor |
|
91
|
301
|
9ri4A |
Sars-cov-2 with a bound inhibitor |
|
74
|
301
|
9ri5A |
Sars-cov-2 with a bound inhibitor |
|
79
|
304
|
9ri0A |
Sars-cov-2 3cl protease with a bound inhibitor |
